Benefit and Risk on Drug-drug Interactions in Infections

1,046
Total downloads
5,899
Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 16 Apr 2025

Synergistic effects of recombinant expressed Fowlicidin and Thymosin α1 hybrid peptides in modulating inflammation and infection in avian macrophages

Baseer Ahmad
Zaheer Abbas
Wei Xubiao
Kashif Hussain
Atif Rehman
Si Dayong
Asghar Abbas
Christina Hölzel
Zhang Rijun

doi 10.3389/fmicb.2025.1568451

820 views

EDITORIAL

Accepted on 07 Apr 2025

Editorial: Benefit and risk on drug-drug interactions in infections

Hideo Kato
Nobuhiro Asai
Mao Hagihara

doi 10.3389/fmicb.2025.1600984

103 views

ORIGINAL RESEARCH

Published on 24 Feb 2025

Changes in the blood cyclosporine level after switching from voriconazole to isavuconazole in a patient with aplastic anemia: insights from physiologically based pharmacokinetic model simulation and the Adverse Event Reporting System database study

Chihiro Shiraishi
Hideo Kato
Kazuko Ino
Takuya Iwamoto

doi 10.3389/fmicb.2025.1525991

1,048 views

ORIGINAL RESEARCH

Published on 08 Oct 2024

Drug–drug interactions between letermovir and tacrolimus in Japanese renal transplant recipients simulated using a physiologically based pharmacokinetic model

Takumi Maruyama
Hidefumi Kasai
Yutaka Fukaya
Mitsuru Shiokawa
Toshimi Kimura
Yukihiro Hamada

doi 10.3389/fmicb.2024.1480874

1,117 views

MINI REVIEW

Published on 05 Sep 2024

Drug–drug interactions in the management of non-tuberculous mycobacterial infections

Kazuaki Takeda
Takahiro Takazono
Hiroshi Mukae

doi 10.3389/fmicb.2024.1468383

1,055 views
2 citations

Share on

Frontiers in Microbiology

Frontiers in Microbiology

Antimicrobials, Resistance and Chemotherapy

Impact

5,899Topic views
3,895Article views
1,046Article downloads